Cargando…
Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype
Ischemic preconditioning (IP) of the liver by a brief interruption of the blood flow protects the damage induced by a subsequent ischemia/reperfusion (I/R) preventing parenchymal and nonparenchymal liver cell damage. The discovery of IP has shown the existence of intrinsic systems of cytoprotection...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619783/ https://www.ncbi.nlm.nih.gov/pubmed/26539478 http://dx.doi.org/10.1155/2015/286746 |
_version_ | 1782397182061576192 |
---|---|
author | Alchera, Elisa Imarisio, Chiara Mandili, Giorgia Merlin, Simone Chandrashekar, Bangalore R. Novelli, Francesco Follenzi, Antonia Carini, Rita |
author_facet | Alchera, Elisa Imarisio, Chiara Mandili, Giorgia Merlin, Simone Chandrashekar, Bangalore R. Novelli, Francesco Follenzi, Antonia Carini, Rita |
author_sort | Alchera, Elisa |
collection | PubMed |
description | Ischemic preconditioning (IP) of the liver by a brief interruption of the blood flow protects the damage induced by a subsequent ischemia/reperfusion (I/R) preventing parenchymal and nonparenchymal liver cell damage. The discovery of IP has shown the existence of intrinsic systems of cytoprotection whose activation can stave off the progression of irreversible tissue damage. Deciphering the molecular mediators that underlie the cytoprotective effects of preconditioning can pave the way to important therapeutic possibilities. Pharmacological activation of critical mediators of IP would be expected to emulate or even to intensify its salubrious effects. In vitro and in vivo studies have demonstrated the role of the adenosine A2a receptor (A2aR) as a trigger of liver IP. This review will provide insight into the phenotypic changes that underline the resistance to death of liver cells preconditioned by pharmacological activation of A2aR and their implications to develop innovative strategies against liver IR damage. |
format | Online Article Text |
id | pubmed-4619783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-46197832015-11-04 Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype Alchera, Elisa Imarisio, Chiara Mandili, Giorgia Merlin, Simone Chandrashekar, Bangalore R. Novelli, Francesco Follenzi, Antonia Carini, Rita Biomed Res Int Review Article Ischemic preconditioning (IP) of the liver by a brief interruption of the blood flow protects the damage induced by a subsequent ischemia/reperfusion (I/R) preventing parenchymal and nonparenchymal liver cell damage. The discovery of IP has shown the existence of intrinsic systems of cytoprotection whose activation can stave off the progression of irreversible tissue damage. Deciphering the molecular mediators that underlie the cytoprotective effects of preconditioning can pave the way to important therapeutic possibilities. Pharmacological activation of critical mediators of IP would be expected to emulate or even to intensify its salubrious effects. In vitro and in vivo studies have demonstrated the role of the adenosine A2a receptor (A2aR) as a trigger of liver IP. This review will provide insight into the phenotypic changes that underline the resistance to death of liver cells preconditioned by pharmacological activation of A2aR and their implications to develop innovative strategies against liver IR damage. Hindawi Publishing Corporation 2015 2015-10-11 /pmc/articles/PMC4619783/ /pubmed/26539478 http://dx.doi.org/10.1155/2015/286746 Text en Copyright © 2015 Elisa Alchera et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Alchera, Elisa Imarisio, Chiara Mandili, Giorgia Merlin, Simone Chandrashekar, Bangalore R. Novelli, Francesco Follenzi, Antonia Carini, Rita Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype |
title | Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype |
title_full | Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype |
title_fullStr | Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype |
title_full_unstemmed | Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype |
title_short | Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype |
title_sort | pharmacological preconditioning by adenosine a2a receptor stimulation: features of the protected liver cell phenotype |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619783/ https://www.ncbi.nlm.nih.gov/pubmed/26539478 http://dx.doi.org/10.1155/2015/286746 |
work_keys_str_mv | AT alcheraelisa pharmacologicalpreconditioningbyadenosinea2areceptorstimulationfeaturesoftheprotectedlivercellphenotype AT imarisiochiara pharmacologicalpreconditioningbyadenosinea2areceptorstimulationfeaturesoftheprotectedlivercellphenotype AT mandiligiorgia pharmacologicalpreconditioningbyadenosinea2areceptorstimulationfeaturesoftheprotectedlivercellphenotype AT merlinsimone pharmacologicalpreconditioningbyadenosinea2areceptorstimulationfeaturesoftheprotectedlivercellphenotype AT chandrashekarbangalorer pharmacologicalpreconditioningbyadenosinea2areceptorstimulationfeaturesoftheprotectedlivercellphenotype AT novellifrancesco pharmacologicalpreconditioningbyadenosinea2areceptorstimulationfeaturesoftheprotectedlivercellphenotype AT follenziantonia pharmacologicalpreconditioningbyadenosinea2areceptorstimulationfeaturesoftheprotectedlivercellphenotype AT carinirita pharmacologicalpreconditioningbyadenosinea2areceptorstimulationfeaturesoftheprotectedlivercellphenotype |